Early Response Monitoring Following Radiation Therapy by Using [18F]FDG and [11C]Acetate PET in Prostate Cancer Xenograft Model with Metabolomics Corroboration
We aim to characterize the metabolic changes associated with early response to radiation therapy in a prostate cancer mouse model by 2-deoxy-2-[18F]fluoro-d-glucose ([18F]FDG) and [11C]acetate ([11C]ACT) positron emission tomography, with nuclear magnetic resonance (NMR) metabolomics corroboration....
Main Authors: | Yi-Hsiu Chung, Cheng-Kun Tsai, Chiun-Chieh Wang, Hsi-Mu Chen, Kuan-Ying Lu, Han Chiu, Yu-Chun Lin, Tzu-Chen Yen, Gigin Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/22/11/1946 |
Similar Items
-
FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
by: Sébastien Thureau, et al.
Published: (2018-10-01) -
Appropriateness criteria of FDG PET/CT in oncology
by: Archi Agrawal, et al.
Published: (2015-04-01) -
18F‐FDG PET/CT imaging: A supplementary understanding of pulmonary sclerosing pneumocytoma
by: Jie Xu, et al.
Published: (2019-07-01) -
Prognostic superiority of International Prognostic Index over [18F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder
by: F. Montes de Jesus, et al.
Published: (2021-03-01) -
2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease
by: U. Plöckinger, et al.
Published: (2018-03-01)